Astrana Health (ASTH) Revenue (2010 - 2026)

Astrana Health has reported Revenue for 17 years, with the latest figure at $965.1 million in Q1 2026.

• Quarterly Revenue rose 55.56% year-over-year to $965.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 56.69% YoY) and the FY2025 annual result came in at $3.2 billion, up 56.39% from the prior year.
• Revenue improved to $965.1 million in Q1 2026 per ASTH's latest filing, from $950.5 million in the prior quarter.
• Over five years, Revenue peaked at $965.1 million in Q1 2026 and troughed at $263.3 million in Q1 2022.
• A 5-year average of $512.5 million and a median of $404.4 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2023 and 2025: Revenue rose 9.83% in 2023, then jumped 99.71% in 2025.
• Over 5 years, Revenue stood at $294.2 million in 2022, then increased by 20.0% to $353.0 million in 2023, then jumped by 88.43% to $665.2 million in 2024, then surged by 42.89% to $950.5 million in 2025, then grew by 1.53% to $965.1 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $965.1 million, $950.5 million, and $956.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.